Physician profile
George R Sosenko
NPI 1881680411
$9,603.40
in general payments reported to CMS, 2019-2025
37 companies · $863 in 2025
The $863 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $752 · 2020: $2,251 · 2021: $1,949 · 2022: $1,235 · 2023: $1,309 · 2024: $1,245 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,332 · Education: $69.99 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,332.37 |
| Education | $69.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gyrus Acmi, INC. | $1,800.00 | 2020 | |
| Antares Pharma, INC. | $1,241.68 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $758.11 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $564.37 | 2020-2025 | Lupron Depot |
| Medivators INC. | $500.00 | 2021 | |
| Teleflex LLC | $477.51 | 2021-2025 | Barrigel |
| Pfizer INC. | $455.17 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $310.54 | 2019-2022 | |
| Medtronic, INC. | $289.06 | 2021-2024 | Signia, Interstim |
| Janssen Biotech, INC. | $280.19 | 2023-2024 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $266.62 | 2022-2025 | |
| Myovant Sciences INC. | $261.84 | 2021-2022 | |
| Urovant Sciences INC | $261.26 | 2022 | |
| Boston Scientific Corporation | $247.01 | 2020-2025 | Rezum Generator, Axonics, Advance Xp |
| Sumitomo Pharma America, INC. | $241.45 | 2023-2024 | Orgovyx, Gemtesa |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $235.20 | 2021-2024 | Soltive, Soltive, Shockpulse |
| Allergan, INC. | $226.92 | 2020-2022 | |
| Halozyme INC | $183.06 | 2023 | |
| Metuchen Pharmaceuticals | $170.80 | 2019 | |
| Neotract INC. | $117.64 | 2020-2021 | |
| Procept Biorobotics Corporation | $91.08 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $87.04 | 2021-2024 | Axonics |
| 180 Medical, INC. | $75.52 | 2023-2024 | Cure Catheter, Gentlecath |
| Tolmar, INC. | $74.66 | 2023-2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $58.70 | 2021-2024 | Prolaris, Myrisk |
| Clarus Therapeutics INC. | $49.81 | 2021 | |
| Novartis Pharmaceuticals Corporation | $44.87 | 2022-2025 | |
| Kerecis Limited | $42.66 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Blue Earth Diagnostics | $33.40 | 2021 | |
| Laborie Medical Technologies Corp. | $28.74 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Agiliti Surgical, INC. | $25.91 | 2025 | Koelis Trinity Mri/US Fusion |
| Profound Medical Corp. | $23.51 | 2025 | Tulsa-Pro |
| Dendreon Pharmaceuticals LLC | $21.48 | 2025 | Provenge |
| Accord Healthcare, INC. | $17.06 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $16.85 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.56 | 2019 | |
| Karl Storz Endoscopy-America | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Sosenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.